Apollo Hospitals has received relief from the Reserve Bank of India (RBI) after the central bank settled alleged violations under the Foreign Exchange Management Act (FEMA) through a compounding process.
The RBI accepted a payment of ₹17.76 crore from Apollo Hospitals and certain directors to resolve the matter, bringing an end to a long-running regulatory issue related to foreign exchange transactions. Compounding is a mechanism that allows entities to settle FEMA violations by paying a monetary amount without undergoing prolonged legal proceedings.
The case was linked to alleged contraventions involving overseas investments and related transactions. Following the settlement, the Enforcement Directorate’s earlier proceedings connected to the matter are expected to lose significance, providing a major relief to the healthcare company and its management.
Apollo Hospitals informed stock exchanges that the RBI’s compounding order does not amount to an admission of guilt. The company stated that the settlement was made to resolve the issue and ensure regulatory compliance going forward.
The development removes a key overhang that had been hanging over the company for several years. Market participants generally view the resolution positively, as it reduces uncertainty and allows management to focus on business operations and expansion plans.
Founded by Dr. Prathap C. Reddy, Apollo Hospitals is one of India’s largest healthcare providers, with a network of hospitals, pharmacies and diagnostic centres across the country. The group has played a significant role in expanding private healthcare services in India.
Legal and regulatory experts noted that compounding provisions under FEMA are designed to encourage voluntary compliance and provide a quicker resolution mechanism for procedural and technical violations. Such settlements help avoid lengthy litigation while ensuring adherence to foreign exchange regulations.
For investors, the RBI’s decision brings clarity on a matter that had remained unresolved for years. Analysts said the settlement strengthens visibility around the company’s regulatory position and removes a potential distraction for management.
With the issue now settled, Apollo Hospitals is expected to continue focusing on healthcare delivery, digital health initiatives and capacity expansion, while maintaining compliance with evolving regulatory requirements.
Also Read: Chennai hospital unveils advanced heart rhythm technology